ArticleClinical and experimental immunology2024

Reduced IFNL1 and/or IFNL2, but not IFNL3 is associated with worse outcome in patients with COVID-19.

Elena Woods et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.